1,1-Cyclobutanedicarboxylatodiammineplatinum (II) CAS:41575-94-4

1,1-Cyclobutanedicarboxylatodiammineplatinum (II) has potential applications in various fields, including: Medicinal Chemistry: Carboplatin is a widely used chemotherapy drug for the treatment of various types of cancer, including ovarian, lung, and brain cancers. Its mechanism of action involves binding to DNA and interfering with cell division, leading to cell death. Compared to cisplatin, carboplatin has a lower risk of side effects, making it a preferred choice for some patients. Materials Science: The compound's unique structure and reactivity make it a valuable precursor for the synthesis of advanced materials, including metal nanoparticles, coordination polymers, and metal-organic frameworks. These materials have potential applications in fields such as catalysis, sensing, and energy storage. Coordination Chemistry: The compound serves as a model system for studying the coordination chemistry of platinum and other transition metals, providing insights into metal-ligand interactions and reactivity. Research and Development: Carboplatin continues to be a subject of research for the development of new therapeutic agents and understanding the mechanisms of action of metal-based drugs. Overall, 1,1-Cyclobutanedicarboxylatodiammineplatinum (II) has potential applications in medicinal chemistry, materials science, and fundamental research. Its use as a chemotherapy drug has had a significant impact on cancer treatment, and ongoing investigation of its properties and reactivity may lead to the development of novel materials and therapeutic agents.